Literature DB >> 22899032

Glasgow outcome scale at hospital discharge as a prognostic index in patients with severe traumatic brain injury.

Rosmari A R A Oliveira1, Sebastião Araújo, Antonio L E Falcão, Silvia M T P Soares, Carolina Kosour, Desanka Dragosavac, Eliane A Cintra, Ana Paula D Cardoso, Rosana A Thiesen.   

Abstract

OBJECTIVE: Evaluate the Glasgow outcome scale (GOS) at discharge (GOS-HD) as a prognostic indicator in patients with traumatic brain injury (TBI).
METHOD: Retrospective data were collected of 45 patients, with Glasgow coma scale <8, age 25±10 years, 36 men, from medical records. Later, at home visit, two measures were scored: GOS-HD (according to information from family members) and GOS LATE (12 months after TBI).
RESULTS: At discharge, the ERG showed: vegetative state (VS) in 2 (4%), severe disability (SD) in 27 (60%), moderate disability (MD) in 15 (33%) and good recovery (GR) in 1 (2%). After 12 months: death in 5 (11%), VS in 1 (2%), SD in 7 (16%), MD in 9 (20%) and GR in 23 (51%). Variables associated with poor outcome were: worse GOS-HD (p=0.03), neurosurgical procedures (p=0.008) and the kind of brain injury (p=0.009).
CONCLUSION: The GOS-HD was indicator of prognosis in patients with severe TBI.

Entities:  

Mesh:

Year:  2012        PMID: 22899032     DOI: 10.1590/s0004-282x2012000800009

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Windowed multitaper correlation analysis of multimodal brain monitoring parameters.

Authors:  Rupert Faltermeier; Martin A Proescholdt; Sylvia Bele; Alexander Brawanski
Journal:  Comput Math Methods Med       Date:  2015-03-03       Impact factor: 2.238

2.  Efficacy of Simultaneous Administration of Nimodipine, Progesterone, and Magnesium Sulfate in Patients with Severe Traumatic Brain Injury: A Randomized Controlled Trial.

Authors:  Ali Abdoli; Farshid Rahimi-Bashar; Saadat Torabian; Sepideh Sohrabi; Hamid Reza Makarchian
Journal:  Bull Emerg Trauma       Date:  2019-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.